0.10Open0.10Pre Close0 Volume461 Open Interest15.00Strike Price0.00Turnover6548.21%IV16.62%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0883Delta0.0689Gamma178.70Leverage Ratio-125.1798Theta0.0000Rho-15.77Eff Leverage0.0001Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet